Latest Articles
Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR) - The Manila Times
Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR) The Manila Times
Published: June 24, 2026, 10:48 a.m.
Absci Reports Positive Phase 1 Results for ABS-201, a First-in-Class PRLR Antibody for Hair Regrowth and Endometriosis – Minichart - Minichart
Absci Reports Positive Phase 1 Results for ABS-201, a First-in-Class PRLR Antibody for Hair Regrowth and Endometriosis – Minichart Minichart
Published: June 24, 2026, 10:45 a.m.
Taking the combined oral contraceptive pill can increase binge eating, study suggests - MSN
Taking the combined oral contraceptive pill can increase binge eating, study suggests MSN
Published: June 24, 2026, 10:43 a.m.
Catheter-Based OCT May Help ID Early Endometrial Cancer - Ophthalmology Advisor
Catheter-Based OCT May Help ID Early Endometrial Cancer Ophthalmology Advisor
Published: June 24, 2026, 4 a.m.
TIUMBIO CEO Hun-Taek Kim Purchases 300 Million Won Worth of Shares on the Open Market - 아시아경제
TIUMBIO CEO Hun-Taek Kim Purchases 300 Million Won Worth of Shares on the Open Market 아시아경제
Published: June 23, 2026, 11:36 p.m.
Catheter-Based OCT May Help ID Early Endometrial Cancer - HealthDay
Catheter-Based OCT May Help ID Early Endometrial Cancer HealthDay
Published: June 23, 2026, 2:05 p.m.
Where to preorder Pokémon Pokopia before release day - Mashable
Where to preorder Pokémon Pokopia before release day Mashable
Published: June 23, 2026, 9:34 a.m.
Swab-based endometrial cancer test wins place in German national guideline - FemTech World
Swab-based endometrial cancer test wins place in German national guideline FemTech World
Published: June 22, 2026, 3:11 p.m.
Medicus Pharma to Showcase SkinJect® Registrational Strategy and Teverelix® Precision Medicine Program at Bio International 2026 - The Manila Times
Medicus Pharma to Showcase SkinJect® Registrational Strategy and Teverelix® Precision Medicine Program at Bio International 2026 The Manila Times
Published: June 22, 2026, 11:48 a.m.
Medicus Pharma to Showcase SkinJect® Registrational - GlobeNewswire
Medicus Pharma to Showcase SkinJect® Registrational GlobeNewswire
Published: June 22, 2026, 11:30 a.m.
Link copied to clipboard!